Expanding our horizons for the use of transcatheter self-expanding valves: what does the future hold? - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/35673979/
doi: 10.1080/14779072.2022.2085688. Online ahead of print. 1 Cardiovascular department, ASST Santi Paolo Carlo, Milano, Italy. 2 Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan, Italy. 3 Cardio Center, Humanitas Clinical...
Expert commentary: In the near future, new devices should be able to obtain optimal results with a negligible rate of complications. Developments in the design of the delivery system together with refinements in valve technology are desirable to achieve results which are comparable to surgical aortic valve replacement.
What if Valve-in-Valve TAVR fails? Is surgical re-replacement still an option in high-risk patients? A case report.
Source : https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/11705
Redo surgical aortic valve replacement has been the gold standard for the treatment of degenerated bioprostheses; however it carries an inherent risk associated with a reoperative open heart surgery. Valve-in-Valve...
Conclusion/Relevance: We present the case of a complex patient with previous surgical aortic valve and ascending aorta replacement who underwent a transfemoral valve-in-valve TAVI for bioprosthesis degeneration, complicated by valve dislocation requiring surgical reoperation.
Antithrombotic treatment for valve protheses: Which drug, which dose, and when?
Source : https://www.sciencedirect.com/science/article/abs/pii/S0033062022000597?via=ihub
Despite the significant reduction of the overall burden of cardiovascular diseases (CVD), valvular heart disease (VHD) still represents an important cause of CVD morbidity and mortality. While the number of...
/>
Relevance: Our purpose is to examine and discuss the available evidences on the use of antithrombotic treatments in patients with mechanical and biological PHV, with the aim to provide a practical tool for decision making in every day clinical practice.
Clinical outcomes of transcatheter aortic valve replacement stratified by left ventricular ejection fraction: A single centre pilot study
Source : https://www.sciencedirect.com/science/article/pii/S2049080122004721?via=ihub
This is the first reported outcome study of TAVR in patients with heart failure in Kuwait. * Conduction disturbances induced by TAVR was observed in almost half of the patients....
Conclusion: Severe AS with EF
-
Aortic Stenosis Connect4yrKey Points • Source: Annals of Medicine and Surgery • Conclusion: “This is the first reported outcome study of TAVR in patients with HFrEF in Kuwait. Post-TAVR conduction disturbances were observed in almost half Show More
Aortic Stenosis in Elderly Populations: Measuring Value of Patient Shared Decision-Making for Transcatheter Aortic Valve Replacement (TAVR) - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/35639533/
Previous Finance Matters columns in Nursing Administrative Quarterly have emphasized the importance of utilizing financial statements to build and promote a successful evidence-based business case. The latest column addressed return...
Relevance: This column defines utilization of cost-benefit analysis and cost-effectiveness analysis when framing the cost, value, and benefit of an innovative health care intervention.